By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Swedish Orphan Biovitrum 


  76  Stockholm  Sweden
Phone: 46-8-697-20-00 Fax: n/a



Company News
Sobi Release: First Patient Randomized In A Phase II Study Evaluating The Safety And Efficacy Of Anakinra In The Treatment Of Acute Gout 1/11/2017 8:07:41 AM
Sobi And Horizon Pharma (HZNP) Enter Five-Year Distribution Agreement For Ravicti And Ammonaps Outside The United States 12/7/2016 7:31:46 AM
Swedish Orphan Biovitrum AB: Sobi Publishes Its Report For The Third Quarter 2016, Raises Guidance 10/27/2016 11:19:07 AM
European Commission (EC) Approves Transfer Of Marketing Authorisation For Alprolix Sobi 10/3/2016 10:51:06 AM
Swedish Orphan Biovitrum: Milan Zdravkovic Joins Sobi As Senior Vice President, Head Of Research & Development 9/26/2016 7:47:45 AM
Sobi: Elocta Obtains National Reimbursement In Spain, Now Available In The Five Largest Markets In The EU 9/23/2016 8:37:09 AM
New Number Of Shares And Votes In Sobi 8/31/2016 11:15:08 AM
Sobi’s CEO Divests A Portion Of Shares 8/8/2016 11:02:33 AM
Biogen (BIIB) And Sobi To Showcase Long-Term Efficacy And Safety Data From Extended Half-Life Hemophilia Therapies At World Federation Of Hemophilia 2016 World Congress 7/18/2016 9:58:01 AM
Sobi Release: FDA Approves ORFADIN (Nitisinone) Oral Suspension 4/27/2016 6:09:52 AM